Adjusting threshold levels of 17-OHP to reflect gestational age and birth weight might be a safe and efficient strategy to improve screening for CAH in newborns.
Among girls with true central precocious puberty referred to a tertiary center in Israel, nonclassical congenital adrenal hyperplasia was diagnosed in almost 5% of patients.
A case report suggested that combination therapy with growth hormone and anastrozole may improve final height in congenital adrenal hyperplasia.
Chronocort was effective in treating congenital adrenal hyperplasia in a phase 2 trial.
Mortality rates are higher among patients with congenital adrenal hyperplasia.
